Ramkissoon Resham, Rosier Ashley, Iyengar Savitha, Taner Timucin, Sanchez William
Case Western Reserve University, Cleveland, Ohio, USA
Mayo Clinic, Rochester, Minnesota, USA.
BMJ Open Qual. 2025 Jan 11;14(1):e002899. doi: 10.1136/bmjoq-2024-002899.
The Scientific Registry for Transplant Recipients (SRTR) publishes outcomes of all transplant centres in the USA two times a year. The outcomes are publicly available and used by insurance payers and patients to assess the performance of a programme. Poor performance can result in temporary suspension or termination of a transplant programme. The estimated 1-year survival hazard ratio (EHR) is an important metric publicly reported by the SRTR.
The EHR at our institution was 1.13, indicating a graft loss rate that was 13% higher than the national average.
METHODS/INTERVENTION: We defined an improvement in this metric as achieving an EHR of <1.0. Our balance measure was maintaining similar liver transplant volumes and avoiding limiting access to transplant. Using a causality tree, we identified there was no 'real time' assessment of programme risk or objective metric to assess this. An affinity diagram was used to determine high and intermediate risk factors for mortality and graft loss and, using a REDCap form (a web application used to manage our database) to track actual and potential complications, we calculated a weekly 'risk metric' that was introduced at multidisciplinary selection conference meetings.
We remeasured our EHR at each interval release of the SRTR outcomes and found it to be 0.98 and 0.65 after implementing the 'risk metric.' During the intervention period, annual liver transplant volume remained above the baseline measure.
By implementing a 'risk metric' to prospectively assess the risk of a low EHR at transplant selection committee meetings, we were able to reduce the EHR well below the national average without limiting access to liver transplants.
美国移植受者科学注册中心(SRTR)每年两次公布美国所有移植中心的成果。这些成果可公开获取,供保险支付方和患者用于评估项目表现。表现不佳可能导致移植项目暂时中止或终止。估计1年生存风险比(EHR)是SRTR公开报告的一项重要指标。
我们机构的EHR为1.13,表明移植物丢失率比全国平均水平高13%。
方法/干预措施:我们将这一指标的改善定义为实现EHR<1.0。我们的平衡指标是维持相似的肝移植量并避免限制移植机会。通过因果树,我们发现没有对项目风险进行“实时”评估或用于评估此风险的客观指标。使用亲和图确定死亡和移植物丢失的高风险和中风险因素,并使用REDCap表单(一种用于管理我们数据库的网络应用程序)跟踪实际和潜在并发症,我们计算了一个每周“风险指标”,并在多学科选拔会议上引入。
在SRTR成果的每次间隔发布时,我们重新测量了EHR,实施“风险指标”后发现其为0.98和0.65。在干预期间,年度肝移植量保持在基线水平之上。
通过在移植选拔委员会会议上实施“风险指标”来前瞻性评估低EHR风险,我们能够将EHR降低至远低于全国平均水平,同时不限制肝移植机会。